Roivant Operating Income from 2010 to 2026

ROIV Stock

USD 29.45 1.60 5.75%

Roivant Sciences Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2026. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Roivant Sciences generates from its operations. View All Fundamentals

Operating Income

First Reported

2020-06-30

Previous Quarter

-306.2 M

Current Value

-339.2 M

Quarterly Volatility

1.1 B

Covid

Interest Hikes

Check Roivant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roivant Sciences' main balance sheet or income statement drivers, such as Discontinued Operations of 97.9 M, Depreciation And Amortization of 12 M or Interest Expense of 42 M, as well as many indicators such as Price To Sales Ratio of 138, Dividend Yield of 6.0E-4 or PTB Ratio of 3.03. Roivant financial statements analysis is a perfect complement when working with Roivant Sciences Valuation or Volatility modules.

Build AI portfolio with Roivant Stock

Check out the analysis of Roivant Sciences Correlation against competitors.

For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

The evolution of Operating Income for Roivant Sciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Roivant Sciences compares to historical norms and industry peers.

Latest Roivant Sciences' Operating Income Growth Pattern

Below is the plot of the Operating Income of Roivant Sciences over the last few years. Operating Income is the amount of profit realized from Roivant Sciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Roivant Sciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Roivant Sciences' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Roivant Sciences' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Operating Income

Timeline

Roivant Operating Income Regression Statistics

	Arithmetic Mean	(566,049,517)
	Geometric Mean	944,831,930
	Coefficient Of Variation	(233.69)
	Mean Deviation	599,612,475
	Median	(748,490,000)
	Standard Deviation	1,322,788,082
	Sample Variance	1749768.3T
	Range	5.8B
	R-Value	0.14
	Mean Square Error	1828988.5T
	R-Squared	0.02
	Significance	0.59
	Slope	37,096,350
	Total Sum of Squares	27996293T

Roivant Operating Income History

	2026	-1.1 B
	2025	-1.2 B
	2024	-1 B
	2023	4.5 B
	2022	-1.2 B
	2021	-1.4 B
	2020	-1.1 B

Other Fundumenentals of Roivant Sciences

Non Operating Income Net Other

Roivant Sciences Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Property Plant Equipment	Long Term Debt	Short Term Investments	Deferred Long Term Liab	Net Invested Capital	Long Term Investments	Net Working Capital	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Intangible Assets
Total Assets		1.0	0.32	0.07	-0.9	0.85	0.79	0.88	0.01	1.0	-0.23	0.51	0.9	0.6	0.8	0.96	-0.46	0.96	0.86	0.8	-0.94	-0.6
Total Stockholder Equity	1.0		0.33	0.0	-0.88	0.88	0.74	0.87	-0.06	1.0	-0.31	0.52	0.88	0.62	0.77	0.96	-0.46	0.96	0.83	0.79	-0.95	-0.6
Net Tangible Assets	0.32	0.33		0.43	-0.39	0.3	0.43	0.23	-0.1	0.3	-0.39	0.88	0.15	0.24	0.28	0.1	-0.06	0.11	0.13	0.19	-0.15	-0.3
Current Deferred Revenue	0.07	0.0	0.43		-0.16	-0.39	0.59	-0.08	0.66	0.02	0.44	0.35	0.17	-0.28	0.47	-0.18	0.42	-0.18	0.18	0.04	0.18	0.21
Net Debt	-0.9	-0.88	-0.39	-0.16		-0.77	-0.83	-0.71	-0.26	-0.9	0.18	-0.52	-0.69	-0.3	-0.64	-0.85	0.53	-0.85	-0.64	-0.53	0.77	0.43
Retained Earnings	0.85	0.88	0.3	-0.39	-0.77		0.44	0.84	-0.38	0.86	-0.5	0.46	0.66	0.71	0.45	0.9	-0.68	0.9	0.61	0.66	-0.9	-0.72
Accounts Payable	0.79	0.74	0.43	0.59	-0.83	0.44		0.67	0.46	0.76	0.17	0.49	0.77	0.29	0.87	0.65	-0.27	0.65	0.74	0.62	-0.63	-0.42
Net Receivables	0.88	0.87	0.23	-0.08	-0.71	0.84	0.67		-0.2	0.88	-0.06	0.43	0.91	0.84	0.74	0.88	-0.63	0.88	0.9	0.92	-0.95	-0.86
Total Liab	0.01	-0.06	-0.1	0.66	-0.26	-0.38	0.46	-0.2		-0.01	0.64	-0.04	0.03	-0.65	0.15	-0.07	0.09	-0.09	0.06	-0.16	0.22	0.43
Total Current Assets	1.0	1.0	0.3	0.02	-0.9	0.86	0.76	0.88	-0.01		-0.26	0.48	0.89	0.6	0.78	0.97	-0.47	0.97	0.84	0.79	-0.95	-0.59
Short Term Debt	-0.23	-0.31	-0.39	0.44	0.18	-0.5	0.17	-0.06	0.64	-0.26		-0.27	0.09	-0.27	0.08	-0.25	0.0	-0.27	0.18	0.05	0.25	0.13
Property Plant Equipment	0.51	0.52	0.88	0.35	-0.52	0.46	0.49	0.43	-0.04	0.48	-0.27		0.38	0.33	0.34	0.31	-0.23	0.31	0.38	0.39	-0.35	-0.36
Long Term Debt	0.9	0.88	0.15	0.17	-0.69	0.66	0.77	0.91	0.03	0.89	0.09	0.38		0.68	0.9	0.85	-0.35	0.85	0.99	0.93	-0.9	-0.63
Short Term Investments	0.6	0.62	0.24	-0.28	-0.3	0.71	0.29	0.84	-0.65	0.6	-0.27	0.33	0.68		0.53	0.61	-0.44	0.62	0.67	0.81	-0.77	-0.89
Deferred Long Term Liab	0.8	0.77	0.28	0.47	-0.64	0.45	0.87	0.74	0.15	0.78	0.08	0.34	0.9	0.53		0.68	-0.08	0.69	0.87	0.79	-0.73	-0.49
Net Invested Capital	0.96	0.96	0.1	-0.18	-0.85	0.9	0.65	0.88	-0.07	0.97	-0.25	0.31	0.85	0.61	0.68		-0.58	1.0	0.8	0.77	-0.97	-0.62
Long Term Investments	-0.46	-0.46	-0.06	0.42	0.53	-0.68	-0.27	-0.63	0.09	-0.47	0.0	-0.23	-0.35	-0.44	-0.08	-0.58		-0.57	-0.37	-0.48	0.54	0.72
Net Working Capital	0.96	0.96	0.11	-0.18	-0.85	0.9	0.65	0.88	-0.09	0.97	-0.27	0.31	0.85	0.62	0.69	1.0	-0.57		0.8	0.77	-0.97	-0.62
Long Term Debt Total	0.86	0.83	0.13	0.18	-0.64	0.61	0.74	0.9	0.06	0.84	0.18	0.38	0.99	0.67	0.87	0.8	-0.37	0.8		0.94	-0.86	-0.63
Capital Surpluse	0.8	0.79	0.19	0.04	-0.53	0.66	0.62	0.92	-0.16	0.79	0.05	0.39	0.93	0.81	0.79	0.77	-0.48	0.77	0.94		-0.85	-0.81
Short Long Term Debt	-0.94	-0.95	-0.15	0.18	0.77	-0.9	-0.63	-0.95	0.22	-0.95	0.25	-0.35	-0.9	-0.77	-0.73	-0.97	0.54	-0.97	-0.86	-0.85		0.72
Intangible Assets	-0.6	-0.6	-0.3	0.21	0.43	-0.72	-0.42	-0.86	0.43	-0.59	0.13	-0.36	-0.63	-0.89	-0.49	-0.62	0.72	-0.62	-0.63	-0.81	0.72

Click cells to compare fundamentals

About Roivant Sciences Financial Statements

Roivant Sciences investors use historical fundamental indicators, such as Roivant Sciences' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Roivant Sciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	-1.2 B	-1.1 B
Non Operating Income Net Other	64.9 M	68.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Roivant Operating Income from 2010 to 2026

Latest Roivant Sciences' Operating Income Growth Pattern

Roivant Operating Income Regression Statistics

Roivant Operating Income History

Other Fundumenentals of Roivant Sciences

Roivant Sciences Operating Income component correlations

About Roivant Sciences Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Roivant Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY